We will rely on you to help lend your voice and support the biotechnology industry.
Bringing new treatments to patients, support public policies that promote innovation, improve patient access.
BIO International ConventionJune 3-6, 2019
BIO World Congress on Industrial Biotechnology and Ag TechJuly 8-11, 2019
BIO Industry Analysis Reports >>
Save. Advocate. Connect. Join Us.
A listing of all BIO members and subsidiaries.
February 11 - 12, 2019 | New York, New York
Dr. Javitt is Chairman, and CEO of NeuroRx, Inc. He is a physician with a background in clinical medicine (ophthalmology), health economics, and health policy with roles in academia, industry, and two Presidential administrations. Jonathan has a 30 year history of innovative startups in pharmaceutical and medical technology and has played key roles in seven companies with successful exits. He has additionally played key roles in drug development programs for Allergan, Merck, Novartis, Pharmacia, Pfizer, and other leading pharmaceutical companies. In all cases, he has focused on first-in-class drugs for serious or life-threatening medical conditions. Dr. Javitt is a graduate of Princeton, Cornell University Medical College, and The Harvard School of Public Health, which designated him its Alumnus of Merit in 2015. He is the author of more than 200 scientific publications that have been quoted by more than 21,000. He is an adjunct Professor of the Johns Hopkins School of Medicine.
This speaker's sessions: